Early Indications of Future Cognitive Decline: Stable versus Declining Controls
Open Access
- 9 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e74062
Abstract
This study aimed to identify baseline features of normal subjects that are associated with subsequent cognitive decline. Publicly available data from the Alzheimer’s Disease Neuroimaging Initiative was used to find differences in baseline clinical assessments (ADAScog, AVLT, FAQ) between cognitively healthy individuals who will suffer cognitive decline within 48 months and those who will remain stable for that period. Linear regression models indicated an individual’s conversion status was significantly associated with certain baseline neuroimaging measures, including posterior cingulate glucose metabolism. Linear Discriminant Analysis models built with baseline features derived from MRI and FDG-PET measures were capable of successfully predicting whether an individual will convert to MCI within 48 months or remain cognitively stable. The findings from this study support the idea that there exist informative differences between normal people who will later develop cognitive impairments and those who will remain cognitively stable for up to four years. Further, the feasibility of developing predictive models that can detect early states of cognitive decline in seemingly normal individuals was demonstrated.Keywords
This publication has 58 references indexed in Scilit:
- Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classificationNeurobiology of Aging, 2011
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseAnnals of Neurology, 2011
- Automated MRI measures predict progression to Alzheimer's diseaseNeurobiology of Aging, 2010
- Boosting power for clinical trials using classifiers based on multiple biomarkersNeurobiology of Aging, 2010
- Functional Alterations in Memory Networks in Early Alzheimer’s DiseaseNeuroMolecular Medicine, 2010
- Structural MRI biomarkers for preclinical and mild Alzheimer's diseaseHuman Brain Mapping, 2009
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification studyNeuroImage, 2008
- Hippocampal hypometabolism predicts cognitive decline from normal agingNeurobiology of Aging, 2008
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 2008